Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Neurol ; 271(4): 1973-1984, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38151575

ABSTRACT

Plasma biomarkers have emerged as promising tools for identifying amyloid beta (Aß) pathology. Before implementation in routine clinical practice, confounding factors modifying their concentration beyond neurodegenerative diseases should be identified. We studied the association of a comprehensive list of demographics, comorbidities, medication and laboratory parameters with plasma p-tau181, glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) on a prospective memory clinic cohort and studied their impact on diagnostic accuracy for discriminating CSF/amyloid PET-defined Aß status. Three hundred sixty patients (mean age 66.5 years, 55% females, 53% Aß positive) were included. Sex, age and Aß status-adjusted models showed that only estimated glomerular filtration rate (eGFR, standardized ß -0.115 [-0.192 to -0.035], p = 0.005) was associated with p-tau181 levels, although with a much smaller effect than Aß status (0.685 [0.607-0.763], p < 0.001). Age, sex, body mass index (BMI), Charlson comorbidity index (CCI) and eGFR significantly modified GFAP concentration. Age, blood volume (BV) and eGFR were associated with NfL levels. p-tau181 predicted Aß status with 87% sensitivity and specificity with no relevant increase in diagnostic performance by adding any of the confounding factors. Using two cut-offs, plasma p-tau181 could have spared 62% of amyloid-PET/CSF testing. Excluding patients with chronic kidney disease did not change the proposed cut-offs nor the diagnostic performance. In conclusion, in a memory clinic cohort, age, sex, eGFR, BMI, BV and CCI slightly modified plasma p-tau181, GFAP and NfL concentrations but their impact on the diagnostic accuracy of plasma biomarkers for Aß status discrimination was minimal.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Female , Humans , Aged , Male , Ambulatory Care Facilities , Biomarkers , Blood Volume , Demography , tau Proteins
2.
JBJS Case Connect ; 12(2)2022 Apr 01.
Article in English | MEDLINE | ID: mdl-37440671

ABSTRACT

CASE: Atlantoaxial instability (AAI) is a frequent complication of rheumatoid arthritis (RA), but its involvement in intracranial bleeding is unclear. We present a young woman with history of systemic lupus erythematosus and RA who developed 3 episodes of subdural bleeding at the upper cervical spine and cranial level. Imaging tests showed signs of AAI with odontoid deformity. The case was interpreted as recurrent traumatic cervical subdural hemorrhage because of AAI. No new episodes occurred after surgical C1-C2 fixation. CONCLUSION: We report a case that had the association of hemorrhage and C1-2 instability in a patient with RA and lupus erythematosus.


Subject(s)
Arthritis, Rheumatoid , Atlanto-Axial Joint , Joint Instability , Spinal Diseases , Female , Humans , Atlanto-Axial Joint/diagnostic imaging , Atlanto-Axial Joint/surgery , Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/surgery , Spinal Diseases/complications , Hematoma, Subdural/complications , Hemorrhage , Arthritis, Rheumatoid/complications , Joint Instability/diagnostic imaging , Joint Instability/etiology , Joint Instability/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...